Effects of polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I-II hypertension

about

Effects of polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I-II hypertension

Item

http://www.wikidata.org/entity/Q57072263

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Effects of polymorphisms on th ...... s with stage I-II hypertension

@en

Effects of polymorphisms on th ...... s with stage I-II hypertension

@nl

type

Item

label

Effects of polymorphisms on th ...... s with stage I-II hypertension

@en

Effects of polymorphisms on th ...... s with stage I-II hypertension

@nl

prefLabel

Effects of polymorphisms on th ...... s with stage I-II hypertension

@en

Effects of polymorphisms on th ...... s with stage I-II hypertension

@nl

P1476

Effects of polymorphisms on th ...... s with stage I-II hypertension

@en

P2093

Dmitry Sychev

http://www.w3.org/2001/XMLSchema#string

Elena Grishina

http://www.w3.org/2001/XMLSchema#string

Elena Malova

http://www.w3.org/2001/XMLSchema#string

Kristina Ryzhikova

http://www.w3.org/2001/XMLSchema#string

Nadezhda Shikh

http://www.w3.org/2001/XMLSchema#string

Tatiana Morozova

http://www.w3.org/2001/XMLSchema#string

P2860

ABC of hypertension: Blood pressure measurement. Part II-conventional sphygmomanometry: technique of auscultatory blood pressure measurement

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial.

2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients

Genetic factors in drug metabolism.

Characterization of the human MDR1 gene.

Multidrug resistance in the chronic lymphoproliferative disorders.

The role of calcium channel blockers in the treatment of hypertension.

P304

157-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PGPM.S158401

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30288082

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

molecular medicine

P932

6159808

http://www.w3.org/2001/XMLSchema#string